Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
13M
-
Shares change
-
+673K
-
Total reported value, excl. options
-
$167M
-
Value change
-
+$9.08M
-
Put/Call ratio
-
0
-
Number of buys
-
32
-
Number of sells
-
-15
-
Price
-
$12.85
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2022
58 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2022.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13M shares
of 55M outstanding shares and own 23.62% of the company stock.
Largest 10 shareholders include Hudson Executive Capital LP (2.45M shares), Blue Water Life Science Advisors, LP (2.1M shares), Board of Trustees of The Leland Stanford Junior University (1.57M shares), Polar Capital Holdings Plc (1.32M shares), BlackRock Inc. (798K shares), VANGUARD GROUP INC (781K shares), MILLENNIUM MANAGEMENT LLC (718K shares), Altium Capital Management LP (296K shares), DEUTSCHE BANK AG\ (270K shares), and FRED ALGER MANAGEMENT, LLC (266K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.